Offner, Gisela <br/><br/>
Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids.  [electronic resource] 

 -  Transplantation  Nov 2008 
 - 1241-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1534-6080 
<br/><br/><label>Standard No.: </label>10.1097/TP.0b013e318188af15  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adrenal Cortex Hormones--therapeutic use<br/>Antibodies, Monoclonal--adverse effects<br/>Basiliximab<br/>Biopsy<br/>Child<br/>Child, Preschool<br/>Cyclosporine--therapeutic use<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Endpoint Determination<br/>Female<br/>Graft Rejection--prevention & control<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Infant<br/>Kaplan-Meier Estimate<br/>Kidney--pathology<br/>Kidney Transplantation--immunology<br/>Longitudinal Studies<br/>Male<br/>Mycophenolic Acid--analogs & derivatives<br/>Recombinant Fusion Proteins--adverse effects